---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292538847.md"
description: "In Monday's after-market session, several healthcare stocks saw significant movement. Gainers included Shuttle Pharmaceuticals (+56.1%), Medicus Pharma (+7.46%), and SANUWAVE Health (+6.57%). Conversely, losers featured BNB Plus (-18.3%), MBX Biosciences (-13.4%), and China Pharma Holding (-11.19%). The report highlights specific price changes and market capitalizations for these listed companies."
datetime: "2026-07-13T21:05:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292538847.md)
  - [en](https://longbridge.com/en/news/292538847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292538847.md)
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-market session. The company's market cap stands at $1.7 million.
-   **Medicus Pharma** (NASDAQ:MDCX) stock rose 7.46% to $0.4. The market value of their outstanding shares is at $23.0 million.
-   **SANUWAVE Health** (NASDAQ:SNWV) shares rose 6.57% to $12.0. The market value of their outstanding shares is at $100.4 million.
-   **Tempest Therapeutics** (NASDAQ:TPST) shares moved upwards by 5.74% to $1.04. The company's market cap stands at $15.5 million.
-   **Capricor Therapeutics** (NASDAQ:CAPR) stock moved upwards by 5.24% to $21.69. The market value of their outstanding shares is at $1.2 billion.
-   **Impact BioMedical** (AMEX:IBO) stock increased by 4.75% to $0.48. The market value of their outstanding shares is at $47.6 million.

### Losers

-   **BNB Plus** (NASDAQ:BNBX) stock declined by 18.3% to $0.13 during Monday's after-market session. The market value of their outstanding shares is at $2.7 million.
-   **MBX Biosciences** (NASDAQ:MBX) stock decreased by 13.4% to $52.0. The company's market cap stands at $2.9 billion.
-   **China Pharma Holding** (AMEX:CPHI) shares fell 11.19% to $0.56. The company's market cap stands at $23.0 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares fell 8.78% to $0.7. The market value of their outstanding shares is at $36.9 million.
-   **Matinas BioPharma Hldgs** (AMEX:MTNB) shares declined by 8.34% to $0.44. The market value of their outstanding shares is at $4.8 million.
-   **NewGenIvf Group** (NASDAQ:NIVF) stock decreased by 7.81% to $1.3. The market value of their outstanding shares is at $4.7 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SNWV.US](https://longbridge.com/en/quote/SNWV.US.md)
- [MDCX.US](https://longbridge.com/en/quote/MDCX.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [BNBX.US](https://longbridge.com/en/quote/BNBX.US.md)
- [MBX.US](https://longbridge.com/en/quote/MBX.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [TPST.US](https://longbridge.com/en/quote/TPST.US.md)
- [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md)
- [IBO.US](https://longbridge.com/en/quote/IBO.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [MTNB.US](https://longbridge.com/en/quote/MTNB.US.md)
- [NIVF.US](https://longbridge.com/en/quote/NIVF.US.md)
- [MDCXW.US](https://longbridge.com/en/quote/MDCXW.US.md)
- [NIVFW.US](https://longbridge.com/en/quote/NIVFW.US.md)

## Related News & Research

- [MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Rating of "Moderate Buy" from Analysts](https://longbridge.com/en/news/294163609.md)
- [China Pharma Holdings Announces New Capital Raising Agreement](https://longbridge.com/en/news/293531766.md)
- [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)
- [BNB Plus ends Cypress advisory deal, brings BNB treasury management in-house](https://longbridge.com/en/news/294352711.md)
- [UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/294310676.md)